UNIVERSITETET I OSLO has floated a tender for Contract notice: Research and development services and related consultancy services. The project location is Norway and the tender is closing on 13 Aug 2018. The tender notice number is 307072-2018, while the TOT Ref Number is 25009927. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Norway

Summary : Contract notice: Research and development services and related consultancy services

Deadline : 13 Aug 2018

Other Information

Notice Type : Tender

TOT Ref.No.: 25009927

Document Ref. No. : 307072-2018

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : UNIVERSITETET I OSLO
Office Name: Universitetet i Oslo
Address: Klaus Torgårds vei 3 Sogn Arena 4. etasje
Town: Oslo
Postal Code: 0372
Contact Point: Jacob Magne Landsvik
Norway
Email :j.m.landsvik@admin.uio.no
URL :http://uio.no

Tender Details

Object of the contract
Research and development services and related consultancy services

Description: Contract notice: Research and development services and related consultancy services

Authority Type: National or federal Agency/Office
Contact Nature: Services
Procedure: Competitive procedure with negotiation
Document: Contract notice
Regulation: European Economic Area (EEA), with participation by GPA countries
Award criteria: The most economic tender
CPV code: 73000000, 71900000, 73111000, 85145000, 73000000, 71900000, 73111000, 85145000
CPV Description: Research and development services and related consultancy services.

Laboratory services.

Research laboratory services.

Services provided by medical laboratories.

Design and synthesis of chemical substances for pharamceutical development projects

Reference Number : ANSK-0531-18

We have carried out a (high-throughput) screening of 30 000 low molecular substances against our target protein. One of the substances showed activity and selectivity on our target protein. After a silico-design, substances with 10 times high potency were found. We are not looking for a CRO that can help us with furthering development of our substances to improve pharmacology and toxicology properties.

We have carried out a (high-throughput) screening of 30 000 low molecular substances against our target protein. One of the substances showed activity and selectivity on our target protein. After a silico-design, substances with 10 times high potency were found. We are not looking for a CRO that can help us with furthering development of our substances to improve pharmacology and toxicology properties.

Visma notice: https://opic.com/id/aflkenxqkj


Internet address (URL): http://uio.no

Documents

 Tender Notice